Related Experiment Videos
Pyoderma gangrenosum in infants and children
J A Graham1, K K Hansen, L G Rabinowitz
1Department of Pediatrics, Medical College of Wisconsin Milwaukee.
Pediatric Dermatology
|March 1, 1994
Summary
Pyoderma gangrenosum (PG) in children presents differently than in adults, with unique lesion distributions, especially in infants. Systemic corticosteroids are an effective treatment for pediatric cases.
Area of Science:
- Dermatology
- Pediatrics
- Clinical Medicine
Background:
- Pyoderma gangrenosum (PG) is a rare, ulcerative skin condition affecting all ages.
- Childhood PG exhibits distinct features compared to adult presentations, including lesion distribution and associated conditions.
Observation:
- A review of childhood PG cases (<18 years) identified trends in clinical presentation, associated disorders, and treatment.
- The youngest documented case, a 3-week-old infant, highlights the occurrence of PG in early infancy.
- Infants with PG may present with perianal and genital lesions, a distribution less common in other age groups.
Findings:
- While clinical appearance is similar to adults, childhood PG shows different frequencies of associated systemic illnesses, with ulcerative colitis being common in older children.
- Head and facial lesions are more prevalent in children than adults.
- Only one infant in the study had a co-occurring condition (HIV) at disease onset.
Implications:
- Understanding these pediatric-specific differences is crucial for accurate diagnosis and management of pyoderma gangrenosum in children.
- Early recognition and appropriate treatment, such as systemic corticosteroids, can lead to effective outcomes in pediatric PG.
- Further research into the specific triggers and pathogenesis of PG in infants and children is warranted.